n-methyl-3,4-methylenedioxyamphetamine and quinoxalines

n-methyl-3,4-methylenedioxyamphetamine has been researched along with quinoxalines in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's6 (75.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Farfel, GM; Seiden, LS1
Fischer, HS; Humpel, C; Saria, A; Schatz, DS; Zernig, G1
Laverty, R; Russell, BR2
Camarasa, J; Camins, A; Canudas, AM; Escubedo, E; Jiménez, A; Jordà, EG; Pallàs, M; Pubill, D; Sureda, FX; Verdaguer, E1
Ando, RD; Bagdy, G; Benko, A; Ferrington, L; Kelly, PA; Kirilly, E1
Bexis, S; Docherty, JR1
Camarasa, J; Ciudad-Roberts, A; Escubedo, E; Pubill, D1

Other Studies

8 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and quinoxalines

ArticleYear
Role of hypothermia in the mechanism of protection against serotonergic toxicity. I. Experiments using 3,4-methylenedioxymethamphetamine, dizocilpine, CGS 19755 and NBQX.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 272, Issue:2

    Topics: Animals; Body Temperature; Brain Chemistry; Dizocilpine Maleate; Hydroxyindoleacetic Acid; Male; N-Methyl-3,4-methylenedioxyamphetamine; Pipecolic Acids; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Serotonin

1995
MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum.
    The European journal of neuroscience, 2000, Volume: 12, Issue:4

    Topics: Acetylcholine; Animals; Antiparkinson Agents; Corpus Striatum; Diphenhydramine; Dopamine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Histamine H1 Antagonists; In Vitro Techniques; Male; Methysergide; N-Methyl-3,4-methylenedioxyamphetamine; Pyrilamine; Quinoxalines; Rats; Rats, Sprague-Dawley; Serotonin Agents; Serotonin Antagonists; Tritium

2000
Correlation between 5-HT content and uptake site density following (S)-MDMA and dexfenfluramine-induced depletion, and with neuroprotection by the glycine site-specific NMDA antagonist ACEA 1021.
    Annals of the New York Academy of Sciences, 2000, Volume: 914

    Topics: Animals; Animals, Newborn; Brain; Brain Chemistry; Dexfenfluramine; Drug Interactions; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neuroprotective Agents; Paroxetine; Quinoxalines; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Tritium

2000
The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity, and neurotoxicity.
    Pharmacology, biochemistry, and behavior, 2001, Volume: 68, Issue:3

    Topics: Animals; Autoradiography; Body Temperature; Brain Chemistry; Carrier Proteins; Chromatography, High Pressure Liquid; Dexfenfluramine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Male; Membrane Glycoproteins; Membrane Transport Proteins; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neurotoxicity Syndromes; Pyrrolidinones; Quinoxalines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Serotonin; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Stereoisomerism; Telemetry

2001
Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells.
    Toxicology and applied pharmacology, 2004, Apr-15, Volume: 196, Issue:2

    Topics: alpha-Tocopherol; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Caspase 3; Caspases; Cerebellum; Cytochromes c; Dizocilpine Maleate; Drug Interactions; Enzyme Activation; Flow Cytometry; Methamphetamine; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Mitochondria; N-Methyl-3,4-methylenedioxyamphetamine; Neurons; Neuroprotective Agents; Quinoxalines; Rats; Reactive Oxygen Species

2004
Acute and long-term effects of a single dose of MDMA on aggression in Dark Agouti rats.
    The international journal of neuropsychopharmacology, 2006, Volume: 9, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Aggression; Animals; Brain; Glucose; Male; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Pyridines; Quinoxalines; Rats; Receptors, Serotonin, 5-HT1; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Time Factors

2006
Role of alpha1-adrenoceptor subtypes in the effects of methylenedioxy methamphetamine (MDMA) on body temperature in the mouse.
    British journal of pharmacology, 2008, Volume: 153, Issue:3

    Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Body Temperature; Fever; Male; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Prazosin; Quinazolines; Quinoxalines; Receptors, Adrenergic, alpha-1; Thymine

2008
Heteromeric nicotinic receptors are involved in the sensitization and addictive properties of MDMA in mice.
    Progress in neuro-psychopharmacology & biological psychiatry, 2013, Jul-01, Volume: 44

    Topics: Analysis of Variance; Animals; Benzazepines; Brain; Cholinergic Agents; Conditioning, Operant; Dihydro-beta-Erythroidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Hallucinogens; Hyperkinesis; Male; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Protein Binding; Quinoxalines; Radionuclide Imaging; Receptors, Nicotinic; Substance-Related Disorders; Tritium; Varenicline

2013